학술논문
Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors.
Document Type
Article
Author
Source
Journal of Clinical Oncology; 1/20/2012, Vol. 30 Issue 3, p282-290, 9p
Subject
Language
ISSN
0732183X